AURIZON
marbofloxacine+clotrimazole+dexaméthasone
About this veterinary medicine
AURIZON is a veterinary medicine in the form of suspension pour instillation auriculaire containing marbofloxacine+clotrimazole+dexaméthasone. It is marketed by VETOQUINOL. It holds a marketing authorisation in Tunisia under number 108.1192.10.
Characteristics
- Form
- suspension pour instillation auriculaire
- Presentation
- Boîte de 1 flacon de 10ml + 1 canule
- Route of administration
- Auricular route
- Laboratory
- VETOQUINOL
- Country
- France
The TunisieVet app to care for your pet
Vets, adoption and products
Regulatory status — Tunisie
🟢 Marketing authorisation in force
Authorisation no. : 108.1192.10 — Authorisation date : 30/09/2010
⚠️ Regulatory alerts
No alert reported.
🔴 Batch recalls
No batch currently reported as recalled.
📦 Availability in Tunisia
Reported by TunisieVet veterinarians.
No availability information yet.
🔒 Availability reporting is reserved for signed-in veterinarians.
Sources
- dpm verified on 15/08/2026
Last synchronisation : 14/11/2026
Report availability
Sign in to your veterinarian account to report availability.
Log InOnly veterinarians can report availability.
